Nestlé S.A.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Nestlé S.A. Nestlé S.A. is the world's largest food and beverage company, engaged in the manufacture and sale of a wide range of nutrition, health, and wellness products including powdered and liquid beverages such as Nescafé, Nespresso, and Nestea; milk products and ice cream like Nido and Dreyer's; prepared dishes and cooking aids including Maggi soups, sauces, and seasonings; nutrition and health science offerings such as Boost nutritional drinks and Optifast meal replacements; pet care products under Purina brands like Pro Plan and Fancy Feast; confectionery items including KitKat, Smarties, and Aero; bottled water under Perrier, S.Pellegrino, and Nestlé Pure Life; breakfast cereals like Cheerios and Nesquik; infant foods such as Gerber; frozen and refrigerated foods including Stouffer's; and plant-based alternatives like Garden Gourmet burgers. Founded in 1866 and headquartered in Vevey, Switzerland, the company operates in nearly 190 countries worldwide with over 2,000 brands and seven primary categories focused on consumer needs from infancy through adulthood. Nestlé S.A. recently reorganized its global structure in 2025 by merging Latin America and North America into Zone Americas, integrating Greater China into Asia, Oceania, and Africa, and streamlining its executive board to enhance decision-making speed and efficiency; established its water and premium beverage business as an independent unit effective January 1, 2025, valued at CHF 3.3 billion with openness to partnerships; shifted to a more targeted innovation strategy halving new product launches while prioritizing "big bets" like air fryer meals and seasonings expanded across the Americas in 2025; and completed the acquisition of VOWST assets from Seres Therapeutics through Nestlé Health Science in 2024 with ongoing support through 2025.
Company News
Nestle boosts cocoa buying in Brazil, working with farmers to cut fertilizer use
Nestle CEO says Middle East conflict driving inflation, higher supplier costs
Nestlé S.A. (NEST:CA) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Nestlé's $393 Million Brazil Bet Won't Produce Formula Until 2028
Nestlé: Fuel For Growth Is Working, But The Stock Is Fairly Valued
Nestle to build infant formula plant in Brazil as part of $393 million investment
Nestle Inks $1 Billion Deal to Sell Health-Supplements Brands to Private Equity Firm
Nestle to divest mainstream supplements business for $1 billion
India busts firm faking expiry dates, nutrition labels on PepsiCo, Nestle food exports
Coffee Prices Are High. Why Ground Coffee Is Holding Up Better Than K-Cups.
Nestle wants India to consult on food-labelling rules amid debate on packaging warnings
Russian company asks Putin to place Nestle assets under temporary administration, Kommersant reports
Focus: Nestle looks to develop new products to serve users of weight-loss drugs
If I Could Teach All Investors 1 Attitude About the Stock Market, It's This
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (August 2026)
Nestle: Improving Growth, Stronger Cash Flow, And A Reaffirmed Buy Case
Nestle: Better RIG, But The Recovery Still Falls Short
Nestle pushes for simpler US food labels to shed 'Frankenstein' ingredients image
Nestlé Courts New Nespresso Drinkers as Sales Dip
Nestlé S.A. (NEST:CA) Q2 2026 Earnings Call Transcript